Alpha Healthcare Acquisition Corp.
Alpha Healthcare Acquisition Corp. Fundamental Analysis
Alpha Healthcare Acquisition Corp. (AHAC) shows weak financial fundamentals with a PE ratio of 1171.58, profit margin of 94.27%, and ROE of -34.19%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 88.6/100 based on profitability, valuation, growth, and balance sheet metrics. The B+ grade reflects solid fundamentals with room for improvement in valuation or growth.
Fundamental Health Score
We analyze AHAC's fundamental strength across five key dimensions:
Efficiency Score
WeakAHAC struggles to generate sufficient returns from assets.
Valuation Score
ModerateAHAC shows balanced valuation metrics.
Growth Score
WeakAHAC faces weak or negative growth trends.
Financial Health Score
ExcellentAHAC maintains a strong and stable balance sheet.
Profitability Score
WeakAHAC struggles to sustain strong margins.
Key Financial Metrics
Is AHAC Expensive or Cheap?
P/E Ratio
AHAC trades at 1171.58 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, AHAC's PEG of -4.26 indicates potential undervaluation.
Price to Book
The market values Alpha Healthcare Acquisition Corp. at -365.21 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at -21.18 times EBITDA. This is generally considered low.
How Well Does AHAC Make Money?
Net Profit Margin
For every $100 in sales, Alpha Healthcare Acquisition Corp. keeps $94.27 as profit after all expenses.
Operating Margin
Core operations generate -49.20 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-34.19 in profit for every $100 of shareholder equity.
ROA
Alpha Healthcare Acquisition Corp. generates $1.62 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Alpha Healthcare Acquisition Corp. generates limited operating cash flow of $-51.40M, signaling weaker underlying cash strength.
Free Cash Flow
Alpha Healthcare Acquisition Corp. generates weak or negative free cash flow of $-51.95M, restricting financial flexibility.
FCF Per Share
Each share generates $-0.50 in free cash annually.
FCF Yield
AHAC converts -7.06% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
1171.58
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-4.26
vs 25 benchmark
P/B Ratio
Price to book value ratio
-365.21
vs 25 benchmark
P/S Ratio
Price to sales ratio
719.40
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
-6.28
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.62
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-0.34
vs 25 benchmark
ROA
Return on assets percentage
0.02
vs 25 benchmark
ROCE
Return on capital employed
-1.17
vs 25 benchmark
How AHAC Stacks Against Its Sector Peers
| Metric | AHAC Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 1171.58 | 19.09 | Worse (Expensive) |
| ROE | -34.19% | 843.00% | Weak |
| Net Margin | 94.27% | 3730.00% | Weak |
| Debt/Equity | -6.28 | 0.90 | Strong (Low Leverage) |
| Current Ratio | 1.62 | 661.68 | Neutral |
| ROA | 1.62% | -21651.00% (disorted) | Weak |
AHAC outperforms its industry in 1 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Alpha Healthcare Acquisition Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Value, Dividend, Cyclical
EPS CAGR
N/A
Industry Style: Value, Dividend, Cyclical
FCF CAGR
N/A
Industry Style: Value, Dividend, Cyclical